Canada - English - Health Canada

cartier chemicals ltd. - benzalkonium chloride - spray - 5.625% - benzalkonium chloride 5.625% - disinfectants (for agents used on object)

Canada - English - Health Canada

cartier chemicals ltd. - benzalkonium chloride - spray - 1% - benzalkonium chloride 1% - disinfectants (for agents used on object)

Canada - English - Health Canada

cartier chemicals ltd. - benzalkonium chloride - liquid - 1.89% - benzalkonium chloride 1.89% - disinfectants (for agents used on object)

Canada - English - Health Canada

cartier chemicals ltd. - clorophene; o-phenylphenol - liquid - 3.37%; 0.5% - clorophene 3.37%; o-phenylphenol 0.5% - disinfectants (for agents used on object)

Canada - English - Health Canada

cartier chemicals ltd. - benzalkonium chloride - liquid - 1.89% - benzalkonium chloride 1.89% - disinfectants (for agents used on object)

Canada - English - Health Canada

cartier chemicals ltd. - benzalkonium chloride - liquid - 1.89% - benzalkonium chloride 1.89% - disinfectants (for agents used on object)

Canada - English - Health Canada

cartier chemicals ltd. - benzalkonium chloride - liquid - 4% - benzalkonium chloride 4% - disinfectants (for agents used on object)

Canada - English - Health Canada

cartier chemicals ltd. - benzalkonium chloride - liquid - 1.89% - benzalkonium chloride 1.89% - disinfectants (for agents used on object)

Canada - English - Health Canada

cartier chemicals ltd. - benzalkonium chloride; octyl decyl dimethyl ammonium chloride; dioctyl dimethyl ammonium chloride; didecyl dimethyl ammonium chloride - liquid - 2.20%; 1.65%; 0.66%; 0.99% - benzalkonium chloride 2.20%; octyl decyl dimethyl ammonium chloride 1.65%; dioctyl dimethyl ammonium chloride 0.66%; didecyl dimethyl ammonium chloride 0.99% - disinfectants (for agents used on object)

Australia - English - Department of Health (Therapeutic Goods Administration)

device technologies australia pty ltd - 56297 - cartilage biomatrix implant - jointrep is an arthroscopic injectable sterile device used in conjunction with a bone marrow stimulation technique (e.g. microfracture) for the repair of articular cartilage lesions. it is administered arthroscopically after preparation and it does not require any mixing with patients blood. within a few minutes, jointrep forms a solid hydrogel within the cartilage defects. as it is a self-gelling device, it relies only on its own characteristics to act as intended. jointrep? injectable implant is indicated for implantation for the treatment of isolated cartilage defects grade iii and iv (icrs/outerbridge scores) of the knee joint in combination with microfracture surgery. use of the implant is not appropriate in the presence of more generalised degeneration, meniscal deficiency or established osteoarthritis.